دورية أكاديمية
Radiotherapy resources in the Philippines: A 2022 update.
| العنوان: | Radiotherapy resources in the Philippines: A 2022 update. |
|---|---|
| المؤلفون: | Canal JPA; Division of Radiation Oncology, Department of Radiology, University of the Philippines, Philippine General Hospital, Manila, the Philippines., Eala MAB; College of Medicine, University of the Philippines, Manila, the Philippines; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, USA. Electronic address: MEala@mednet.ucla.edu., Arevalo MVPN; Department of Dermatology, University of the Philippines, Philippine General Hospital, Manila, the Philippines., Dee EC; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Co HCS; Division of Radiation Oncology, Department of Radiology, University of the Philippines, Philippine General Hospital, Manila, the Philippines. |
| المصدر: | Journal of cancer policy [J Cancer Policy] 2024 May 18; Vol. 41, pp. 100485. Date of Electronic Publication: 2024 May 18. |
| Publication Model: | Ahead of Print |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101639933 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-5383 (Electronic) Linking ISSN: 22135383 NLM ISO Abbreviation: J Cancer Policy Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: [London] : Elsevier Ltd, [2013]- |
| مستخلص: | Background: Cancer is the third leading cause of death in the Philippines. Radiotherapy (RT) is integral to the treatment and palliation of cancer. Therefore, RT resources across the country must be surveyed and optimized. Methods: Online surveys were sent to the heads of all 50 RT facilities in the Philippines. The survey included items regarding the facility itself, personnel, and available services. Findings: The survey had a 98% response rate. 76% of RT facilities in the Philippines are privately owned; 12 are government/public institutions and 8 are academic centers. Over a third are in the National Capital Region; three regions are without a single RT facility. For a population of >110 million, the Philippines has 53 linear accelerators, 125 radiation oncologists, 56 residents, 114 medical physicists, 113 radiation oncology nurses, and 343 radiation therapists. Nine radiation oncology residency programs are active. All facilities are capable of 3D conformal radiotherapy, and 96% are capable of intensity modulated radiotherapy. <30% offer stereotactic radiotherapy, and <50% offer HDR brachytherapy. Conclusion: While there has been significant expansion of RT resources over the years, RT remains inaccessible for many in the Philippines. Urgent investment in training and retaining RT personnel is needed as well. Policy summary: With its current cancer burden, the Philippines needs at least 170 linear accelerators, 300 radiation oncologists, and 150 medical physicists. Public/government cancer centers must be built, with priority given to regions without RT facilities. HDR brachytherapy and stereotactic radiotherapy services must also be expanded. A national RT task force must be created to ensure the quality, availability, and accessibility of RT in the Philippines. Further work exploring payment schemes that improve access to RT and mitigate financial toxicity is needed, as well as integration of radiation oncology providers and health policy experts into national health system decision making. Competing Interests: Declaration of Competing Interest ECD is funded in part through the Cancer Center Support Grant from the National Cancer Institute (P30 CA008748). All other authors have no conflict of interest to declare. (Copyright © 2024 Elsevier Ltd. All rights reserved.) |
| فهرسة مساهمة: | Keywords: Cancer workforce; Global health; Global oncology; Philippines; Radiation oncology disparities; Radiation oncology resources; Radiotherapy; Southeast Asia |
| تواريخ الأحداث: | Date Created: 20240520 Latest Revision: 20240529 |
| رمز التحديث: | 20240530 |
| DOI: | 10.1016/j.jcpo.2024.100485 |
| PMID: | 38768855 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 2213-5383 |
|---|---|
| DOI: | 10.1016/j.jcpo.2024.100485 |